Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
Date:11/13/2008

Company prepares to launch Moxatag(TM), the first and only FDA-approved

once-daily amoxicillin, in the first quarter of 2009
GERMANTOWN, Md., Nov. 13 /PRNewswire-FirstCall/ --

Highlights

-- MiddleBrook Pharmaceuticals received stockholder approval for and

closed a $100 million financing transaction with Equity Group

Investments, L.L.C. (EGI). (Sept.)

-- MiddleBrook repurchased the Keflex(R) assets for approximately $11.0

million from Deerfield Management and redeemed the Deerfield warrant

for $8.8 million in conjunction with the EGI transaction. (Sept.)

-- John Thievon became president & CEO, and David Becker became executive

vice president & CFO effective upon the close of the EGI transaction.

(Sept.)

-- The MiddleBrook team was expanded to include additional senior leaders

with proven track records in commercial operations. (Sept. - Nov.)

-- MiddleBrook engaged TalenTactics(TM) to lead its national sales force

hiring efforts and teamed with VCG & Associates to obtain managed-care

coverage for Moxatag (extended-release amoxicillin) Tablets, 775mg.

(Oct.)

-- The Company's Moxatag patents were listed in FDA's Orange Book. (Oct.)

-- MiddleBrook President & CEO John Thievon presented at the 10th Annual

Rodman & Renshaw Healthcare Conference. (Nov.)

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced financial and operational results for the quarter ended Sept. 30, 2008.

MiddleBrook President & CEO John Thievon said, "We have made significant progress since September. We have expanded the MiddleBrook senior leadership team, and our accomplished sc
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
3. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
4. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
5. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
6. MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
7. MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman & Renshaw Healthcare Conference
8. MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
9. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
10. MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Benefit Express Services, LLC, a leader in ... will be hosting a free Workplace Wellness webinar on ... The presentation will focus on making sure your workplace ... Health Care Reform Requirements. The team will also share ... Express regularly hosts free educational webinars on issues that ...
(Date:5/21/2013)... Three major Ohio universities and four hospitals have ... a new collaborative research program aimed exclusively at finding ... Dimes intends to invest $10 million in the program ... Prematurity Research Center -- Ohio Collaborative is a unique ... the March of Dimes. "This new transdisciplinary, team-based research ...
(Date:5/21/2013)... 2013 EMBO announced today that 52 outstanding researchers ... membership. Forty-three of the researchers reside in Europe and ... nine Associate Members from Canada, China, India, Japan and ... 1600 life scientists. , "Our members are the basis ... Maria Leptin said. "We have been building our network ...
(Date:5/21/2013)... Healthcare Solutions, the parent company ... announced that it was honored to receive the ... Conferred annually, the Innovation Award recognizes a ... cutting edge programs that improves cost and/or quality ... for its clinical and IT solutions that have ...
(Date:5/21/2013)... Two-thirds of patients who have been diagnosed ... that they engage in at least one type of ... findings from the National Health and Wellness Survey ... research will be presented today at the 18th Annual ... Outcomes Research) in New Orleans. , “Cancer ...
Breaking Medicine News(10 mins):Health News:Benefit Express to Host Workplace Wellness Webinar 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3Health News:EMBO announces 52 new members for 2013 2Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3
... By Jenifer Goodwin HealthDay Reporter , MONDAY, Sept. ... more likely to suffer socially and emotionally than their normal-weight ... in Australia checked children,s BMI, a measure of height and ... few years later. Parents and teachers filled out questionnaires that ...
... , MONDAY, Sept. 19 (HealthDay News) -- More than ... attack are delayed in getting the emergency artery-opening intervention ... from the fact that only a quarter of American ... that many patients who experience a so-called "ST-segment elevation ...
... D.C. Psychosocial stress could play a role in ... populations, according to study results presented at the Fourth ... held here from Sept. 18-21, 2011. "We found ... reported higher levels of stress than whites, and that ...
... COLUMBIA, Mo. For medications to be effective, they must ... time, as prescribed by healthcare providers. The World Health ... incorrectly, costing the U.S. health care system and consumers ... University of Missouri researchers say medication non-adherence interventions should ...
... effects of cancer treatments. Beth Faiman MSN, ... School of Nursing at Case Western Reserve University, is ... effects for people with blood and bone marrow cancers. ... 1994 at the Cleveland Clinic Taussig Cancer Center with ...
... , MONDAY, Sept. 19 (HealthDay News) -- American youngsters ... than their northern neighbors due to a public health policy ... 4-year olds, according to a Canadian-American research team. The ... the U.S. Advisory Committee on Immunization Practices in 2006. To ...
Cached Medicine News:Health News:Obese Kids May Face Social, Emotional Woes 2Health News:Obese Kids May Face Social, Emotional Woes 3Health News:One-Third of Severe Heart Attack Patients Have Treatment Delays 2Health News:Integrating medication regimens into daily routines can improve adherence 2Health News:CWRU research examines over-the-counter drug's effect on chemo's side effects 2Health News:U.S. Flu Shot Policy Shields More Kids Than Canada's Program, Study Finds 2
(Date:5/21/2013)... May 21, 2013  BioRestorative Therapies, Inc. ("BRT" or ... focused on developing stem cell based therapies for various ... , its President and CEO, will be presenting at ... will be held on Thursday, May 30, 2013 at ... Street in New York City.  Mr. Weinreb,s presentation will ...
(Date:5/21/2013)... May 21, 2013  AcelRx Pharmaceuticals, Inc. ... pharmaceutical company focused on the development and ... of acute and breakthrough pain, today announced ... Phase 3 study of its investigational sublingual ... System), the primary efficacy endpoint was achieved.  ...
(Date:5/21/2013)...   RxAlly , a first-of-its-kind alliance of ... publication of a white paper entitled Personalized Pharmacist ... white paper highlights an unprecedented solution for improving ... to avert strains on the health care system. ... range of individually-tailored, pharmacist-provided clinical and consultative services ...
Breaking Medicine Technology:BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 2RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 3
... 2011 Verilogue, the physician-patient dialogue expert, today ... initiatives, including CareCoach.com, the company,s unique service that ... caregivers and their physicians. The company will be ... e-Patient Connections; the Hyatt at Bellevue; ...
... YORK, Sept. 20, 2011 Reportlinker.com announces ... available in its catalogue: ... Outlook to 2017 ... Africa Cardiovascular Devices Market Outlook to 2017 ...
Cached Medicine Technology:Verilogue to Present at Upcoming Health IT and Patient-Focused Conferences 2Middle East and Africa Cardiovascular Devices Market Outlook to 2017 2Middle East and Africa Cardiovascular Devices Market Outlook to 2017 3Middle East and Africa Cardiovascular Devices Market Outlook to 2017 4Middle East and Africa Cardiovascular Devices Market Outlook to 2017 5Middle East and Africa Cardiovascular Devices Market Outlook to 2017 6Middle East and Africa Cardiovascular Devices Market Outlook to 2017 7Middle East and Africa Cardiovascular Devices Market Outlook to 2017 8Middle East and Africa Cardiovascular Devices Market Outlook to 2017 9Middle East and Africa Cardiovascular Devices Market Outlook to 2017 10Middle East and Africa Cardiovascular Devices Market Outlook to 2017 11Middle East and Africa Cardiovascular Devices Market Outlook to 2017 12Middle East and Africa Cardiovascular Devices Market Outlook to 2017 13Middle East and Africa Cardiovascular Devices Market Outlook to 2017 14Middle East and Africa Cardiovascular Devices Market Outlook to 2017 15Middle East and Africa Cardiovascular Devices Market Outlook to 2017 16Middle East and Africa Cardiovascular Devices Market Outlook to 2017 17
... Tango exercise BP monitor is designed to ... and diastolic BP along with heart rate. ... for use in treadmill, ergometer and pharmacological ... for use in research environments., ,Tango ...
...
...
... Tamp is an orthopedic balloon designed to ... Like an angioplasty balloon, it can be ... is inflated with radiopaque contrast medium. The ... volume. The force of balloon growth compacts ...
Medicine Products: